ANIP vs ORCL · rev $503.5M vs P/E 31, rev $67.36B
ANI Pharmaceuticals Inc (ANIP) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
ANIP currently screens at market cap $1.41B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the ANIP and ORCL stock pages for the full models.
Not investment advice.